Perioperative Fully Closed-loop Versus Usual Care Glucose Management in Adults Undergoing Major Abdominal Surgery
Authors:
- Gabija KrutkyteGKGabija Krutkyte
- Arna M.C. GoergAGArna M.C. Goerg
- Christian A. GrobCGChristian A. Grob
- Camillo D. PiazzaCPCamillo D. Piazza
- Eva-Dorothea RolfesEREva-Dorothea Rolfes
- Beat GloorBGBeat Gloor
- Anna S. WenningAWAnna S. Wenning
- Guido BeldiGBGuido Beldi
- Otto KollmarOKOtto Kollmar
- Roman HovorkaRHRoman Hovorka
- Malgorzata E. WilinskaMWMalgorzata E. Wilinska
- David HerzigDHDavid Herzig
Open Access
- 30 September 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 281 (5) , 732-740
Abstract
Objective: To assess the efficacy and safety of fully closed-loop (FCL) compared with usual care (UC) glucose control in patients experiencing major abdominal surgery-related stress hyperglycemia. Background: Major abdominal surgery-related stress and periprocedural interventions predispose to perioperative hyperglycemia, both in diabetes and non-diabetes patients. Insulin corrects hyperglycemia effectively, but its safe use remains challenging. Methods: In this two-centre randomized controlled trial, we contrasted subcutaneous FCL with UC glucose management in patients undergoing major abdominal surgery anticipated to experience prolonged hyperglycemia. FCL (CamAPS HX, Dexcom G6, mylife YpsoPump 1.5x) or UC treatment was used from hospital admission to discharge (max 20 d). Glucose control was assessed using continuous glucose monitoring (masked in the UC group). The primary outcome was the proportion of time with sensor glucose values in a target range of 5.6 to 10.0 mmol/L. Results: Thirty-seven surgical patients (54% pancreas, 22% liver, 19% upper gastrointestinal, 5% lower gastrointestinal), of whom 18 received FCL and 19 UC glucose management, were included in the analysis. The mean ± SD percentage time with sensor glucose in the target range was 80.1% ± 10.0% in the FCL and 53.7% ± 19.7% in the UC group (P < 0.001). Mean glucose was 7.5 ± 0.5 mmol/L in the FCL and 9.1 ± 2.4 mmol/L in the UC group (P = 0.015). Time in hypoglycemia (<3.0 mmol/L) was low in either group. No study-related serious adverse events occurred. Conclusions: The FCL approach resulted in significantly better glycemic control compared with UC management, without increasing the risk of hypoglycemia. Automated glucose-responsive insulin delivery is a safe and effective strategy to minimize hyperglycemia in complex surgical populations.Keywords
This publication has 52 references indexed in Scilit:
- Glucose Control and the Inflammatory ResponseNutrition in Clinical Practice, 2008
- Diabetes care in hospitalized noncritically ill patients: More evidence for clinical inertia and negative therapeutic momentumJournal of Hospital Medicine, 2007
- Therapy Insight: the effect of tight glycemic control in acute illnessNature Clinical Practice Endocrinology & Metabolism, 2007
- Glycemic Control, Diabetic Status, and Mortality in a Heterogeneous Population of Critically Ill Patients Before and During the Era of Intensive Glycemic Management: Six and One-Half Years Experience at a University-Affiliated Community HospitalSeminars in Thoracic and Cardiovascular Surgery, 2006
- Hyperglycemia Is Associated With Adverse Outcomes in Patients Receiving Total Parenteral NutritionDiabetes Care, 2005
- Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetesPhysiological Measurement, 2004
- The method of minimization for allocation to clinical trialsControlled Clinical Trials, 2002
- Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2002
- Insulin resistance after abdominal surgeryBritish Journal of Surgery, 1994
- Insulin Resistance after Surgery: Normalization by Insulin TreatmentClinical Science, 1990